Fentyl 50mcg Injection

Fentanyl transdermal system should be prescribed only by healthcare providers who are knowledgeable about the use of extended-release/long-acting opioids and how to mitigate the associated risks. Use the lowest effective dosage for the shortest duration of time consistent with individual patient treatment goals. Reserve titration to higher doses of fentanyl transdermal system for patients in whom lower doses are insufficiently effective and in whom the expected benefits of using a higher dose opioid clearly outweigh the substantial risks.

Directions from the U.S. FDA-approved label for Fentanyl — your doctor or pharmacist may advise differently.

Fentanyl transdermal system is contraindicated in: patients who are not opioid-tolerant. the management of acute or intermittent pain, or in patients who require opioid analgesia for a short period of time. the management of post-operative pain, including use after outpatient or day surgeries, (e.g., tonsillectomies). the management of mild pain. patients with significant respiratory depression. patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment.

Excerpt from the U.S. FDA-approved label for Fentanyl. Talk to a pharmacist or doctor before use.

Risk of Increased Fentanyl Absorption with Elevated Body Temperature: Regularly evaluate patients with fever closely for sedation and respiratory depression and reduce the dose if necessary. Warn patients to avoid strenuous exertion that may lead to increased body temperature. Opioid Induced Hyperalgesia (OIH) and Allodynia: Opioid-Induced Hyperalgesia (OIH) occurs when an opioid analgesic paradoxically causes an increase in pain, or an increase in sensitivity to pain. If OIH is suspected, carefully consider appropriately decreasing the dose of the current opioid analgesic, or opioid rotation.

Warnings and precautions excerpt from the U.S. FDA-approved label for Fentanyl — not a complete list. Talk to a pharmacist or doctor before use.

The following serious adverse reactions are discussed elsewhere in the labeling: Addiction, Abuse, and Misuse Life-Threatening Respiratory Depression Accidental Exposure Interactions with Benzodiazepines or Other Central Nervous System Depressants Neonatal Opioid Withdrawal Syndrome Opioid-Induced Hyperalgesia and Allodynia Serotonin Syndrome Adrenal Insufficiency Severe Hypotension Gastrointestinal Adverse Reactions Seizures…

Excerpt from the U.S. FDA-approved label for Fentanyl — not a complete list. Talk to a pharmacist or doctor about side effects.

3 brands · 2 makers in the NepalDoc catalog — see the full Fentanyl guide →

Store up to 25°C (77°F);

Storage information from the U.S. FDA-approved label for Fentanyl.